Singular Health Group Ltd (ASX: SHG) has received $99,936 in Innovative Manufacturing Cooperative Research Centre (IMCRC) Activate funding, which will be combined with “in- kind” support from Australia’s peak national science agency, CSIRO, towards an R&D project to develop a Surface Scan to Model extension for the core 3Dicom Surgical software creating “3Dicom Surface”.
The total project has a $538,984 value accounting for cash and in-kind contributions. The program will see each of IMCRC and Singular Health contribute $99,936 in cash towards the project, with the balance provided thought in-kind contributions by the CSIRO and Singular Health.
In addition to developing an Artificial Intelligence Algorithm, CSIRO are also licensing background IP in medical computer aided design capable of future integration into the company’s 3Dicom software.
Singular Health is focused on commercialising the 3Dicom software as the core platform for the Scan to Surgery workflow and jointly developing research and commercial opportunities which fit the company’s vision of delivering better health outcomes.
This Project is further confirmation of the Company’s strong R&D activities and the ability to apply the core 3Dicom software to numerous clinical applications to improve health outcomes and quality of life.
The Company’s focus on collaboratively developing commercial opportunities with existing industry partners for various applications continues to develop extensive channels to market the 3Dicom software, Artificial Intelligence (AI) models, and 3D printing of personalised medical devices including surgical implants.
The project budget is comprised of $199,872 in cash contributions from IMCRC and Singular Health, with $92,000 in-kind staff and non-staff costs from Singular Health and $247,112 in-kind staff and non-staff costs from CSIRO. Non-staff in-kind contributions include the use of specialist equipment, facilities, servers, and other items needed to advance a technical project of this nature.
Once again, Singular Health has engaged with research organisations to develop additional functionality for our core Scan to Surgery software with a clear commercial outcome,” Thomas Hanly, Singular Health’s Chief Executive Officer, said.
“Working with IMCRC and CSIRO will enable us to expand our product offering beyond radiological imaging into LIDAR and photogrammetric external scans which paves the way for the creation of custom prosthetics, casts and much more.”
